McKesson has been at the forefront of RFID activity in health care since 2004, and has conducted successful pilots with Pfizer and GlaxoSmithKline. The company originally viewed RFID as a means of achieving regulatory compliance for pedigrees. Now, it seeks ways to improve the efficiency and accuracy of its high-volume distribution operations by leveraging serialization and GS1 standards. McKesson is currently undertaking a project with IBM, the objective of which is to identify how trading partners can more effectively manage the cold chain through distribution to customers. In this session, hear about the opportunities RFID presents to organizations, and the challenges executives face when presenting this innovative concept to management for funding.
Speaker: Ron Bone, Senior VP, Distribution Support, McKesson